Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Victor Sanchez Turrion"'
Autor:
Christian Klein, Christophe Duvoux, James J. Powell, Andreas A. Schnitzbauer, Bart van Hoek, Roberto Troisi, Carl Zülke, Johann Hauss, Lionel Rostaing, Itxarone Bilbao, René Adam, J. Gugenheim, Tom M. Ganten, Heiner Wolters, Victor Sanchez Turrion, Fred Fändrich, Koert P. de Jong, Simone I. Strasser, Peter Neuhaus, Silvio Nadalin, Olivier Chazouillères, Christian Graeb, Giorgio Rossi, Michael Heise, Jan Lerut, P. Lamby, André Roy, Karl-Walter Jauch, Gerd Otto, Angela Schlitt, Jens Brockmann, Thomas Becker, Darius F. Mirza, Hans J. Schlitt, Jan Schmidt, Patrizia Burra, Stefan Schreiber, Jürgen Klempnauer, Jacques Pirenne, Ernest Hidalgo, Andrea Proneth, Umberto Cillo, Norman M. Kneteman, Ingrid Mutzbauer, Philippe Wolf, Neville V. Jamieson, Umberto Valente, Philippe Bachellier, Edward K. Geissler, Gunnar Söderdahl, Thomas Soliman, Antonio Daniele Pinna, Sherrie Bhoori, Johann Pratschke, Susanne Beckebaum, Wolf O. Bechstein, Magnus Rizell, T. Scholz, Vincenzo Mazzaferro, Raimund Margreiter, Heikki Mäkisalo, Michele Colledan, Utz Settmacher, Rudolf Steininger, Alfred Königsrainer, Georges-Philippe Pageaux, Markus Rentsch
Publikováno v:
TRANSPLANTATION
Transplantation, 100(1), 116-125
Transplantation
Transplantation, Lippincott, Williams & Wilkins, 2016, 100 (1), pp.116-125. ⟨10.1097/TP.0000000000000965⟩
Transplantation, 100(1), 116-125. LIPPINCOTT WILLIAMS & WILKINS
Transplantation, 100(1), 116-125
Transplantation
Transplantation, Lippincott, Williams & Wilkins, 2016, 100 (1), pp.116-125. ⟨10.1097/TP.0000000000000965⟩
Transplantation, 100(1), 116-125. LIPPINCOTT WILLIAMS & WILKINS
International audience; BACKGROUND:We investigated whether sirolimus-based immunosuppression improves outcomes in liver transplantation (LTx) candidates with hepatocellular carcinoma (HCC).METHODS:In a prospective-randomized open-label international
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a61de4ba31045354e734eec5c58675d
https://hdl.handle.net/1887/117549
https://hdl.handle.net/1887/117549
Autor:
Johann Hauss, Peter Neuhaus, Gerd Otto, Koert P. de Jong, Jan Schmidt, Jean Gugenheim, Hans J. Schlitt, Justine Rochon, Simone I. Strasser, Victor Sanchez Turrion, Giorgio Rossi, Michele Colledan, Ernest Hidalgo, Itxarone Bilbao, Thomas Becker, Darius F. Mirza, Ingrid Mutzbauer, Jan Lerut, Michael Heise, Karl-Walter Jauch, Edward K Geissler, Neville V. Jamieson, Umberto Valente, Christophe Duvoux, Susanne Beckebaum, Bart van Hoek, Magnus Rizell, Philippe Wolf, Olivier Chazouillères, Christian Graeb, Gunnar Söderdahl, Rudolf Steininger, Andreas A. Schnitzbauer, Wolf O. Bechstein, Jacques Pirenne, Lionel Rostaing, Umberto Cillo, Norman M. Kneteman, T. Scholz, Vincenzo Mazzaferro, Raimund Margreiter, André Roy, P. Lamby, Roberto Troisi, Heikki Mäkisalo, Antonio Daniele Pinna, Georges-Philippe Pageaux, Patrizia Burra, René Adam, Carl Zuelke, Heiner Wolters, Alfred Königsrainer, Fred Fändrich
Publikováno v:
BMC Cancer, Vol 10, Iss 1, p 190 (2010)
BMC Cancer, 10
BMC CANCER
BMC Cancer, 10:190. BMC
BMC Cancer
BMC Cancer, Vol. 10, no. 190, p. [1-8] (2010)
BMC Cancer, 10
BMC CANCER
BMC Cancer, 10:190. BMC
BMC Cancer
BMC Cancer, Vol. 10, no. 190, p. [1-8] (2010)
Background The potential anti-cancer effects of mammalian target of rapamycin (mTOR) inhibitors are being intensively studied. To date, however, few randomised clinical trials (RCT) have been performed to demonstrate anti-neoplastic effects in the pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8354c9ed098369310e59e52102c5f616
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7871
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7871